Cargando…
Risk factors for avascular necrosis in patients with systemic lupus erythematosus: a multi-center cohort study of Chinese SLE Treatment and Research Group (CSTAR) Registry XXII
BACKGROUND: Avascular necrosis is a common organ damage in SLE patients, which can influence patients’ life quality. Conflicting results exist in risk factors of AVN in SLE patients. The aim of this study was to illustrate risk factors predicting the occurrence of avascular necrosis (AVN), also know...
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10176939/ https://www.ncbi.nlm.nih.gov/pubmed/37173771 http://dx.doi.org/10.1186/s13075-023-03061-3 |
_version_ | 1785040524377325568 |
---|---|
author | Cheng, Cheng Huang, Can Chen, Zhen Zhan, Feng Duan, Xinwang Wang, Yongfu Zhao, Cheng Wu, Zhenbiao Xu, Jian Li, Hongbin Yang, Min Wu, Rui Zhao, Jiuliang Zhang, Shangzhu Wang, Qian Leng, Xiaomei Tian, Xinping Li, Mengtao Zeng, Xiaofeng |
author_facet | Cheng, Cheng Huang, Can Chen, Zhen Zhan, Feng Duan, Xinwang Wang, Yongfu Zhao, Cheng Wu, Zhenbiao Xu, Jian Li, Hongbin Yang, Min Wu, Rui Zhao, Jiuliang Zhang, Shangzhu Wang, Qian Leng, Xiaomei Tian, Xinping Li, Mengtao Zeng, Xiaofeng |
author_sort | Cheng, Cheng |
collection | PubMed |
description | BACKGROUND: Avascular necrosis is a common organ damage in SLE patients, which can influence patients’ life quality. Conflicting results exist in risk factors of AVN in SLE patients. The aim of this study was to illustrate risk factors predicting the occurrence of avascular necrosis (AVN), also known as osteonecrosis, in systemic lupus erythematosus (SLE) patients in Chinese SLE Treatment and Research Group (CSTAR), a multi-center cohort of Chinese SLE patients. METHODS: SLE patients in CSTAR without existing AVN at registration were included. At least two follow-ups and an observation period of no less than 2 years for AVN event were required. Univariate and multivariate Cox regression analyses were used to evaluate risk factors for AVN in SLE patients. Coefficient B was transformed to risk score for the development of a risk stratification model. RESULTS: One hundred six (2.59%) of 4091 SLE patients were diagnosed AVN during follow-ups of no less than 2 years. Multi-variate Cox regression analysis suggested that SLE onset age ≤ 30 (HR 1.616, p 0.023), arthritis (HR 1.642, p 0.018), existing organ damage (SDI ≥ 1) at registration (HR 2.610, p < 0.001), positive anti-RNP (HR 1.709, p 0.006), and high glucocorticoid maximum daily dose at registration (HR 1.747, p 0.02) were independent risk factors. A risk stratification system was developed according to the risk factors, and patients were divided into high risk (3–6) and low risk (0–2). The AUC of 0.692 indicated moderate discrimination. The calibration curve in internal validation was drawn. CONCLUSION: Patients with SLE onset age ≤ 30, arthritis, existing organ damage (SDI ≥ 1) at registration, positive anti-RNP, and high glucocorticoid maximum daily dose at registration are at high risk for AVN and require attention. |
format | Online Article Text |
id | pubmed-10176939 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-101769392023-05-13 Risk factors for avascular necrosis in patients with systemic lupus erythematosus: a multi-center cohort study of Chinese SLE Treatment and Research Group (CSTAR) Registry XXII Cheng, Cheng Huang, Can Chen, Zhen Zhan, Feng Duan, Xinwang Wang, Yongfu Zhao, Cheng Wu, Zhenbiao Xu, Jian Li, Hongbin Yang, Min Wu, Rui Zhao, Jiuliang Zhang, Shangzhu Wang, Qian Leng, Xiaomei Tian, Xinping Li, Mengtao Zeng, Xiaofeng Arthritis Res Ther Research BACKGROUND: Avascular necrosis is a common organ damage in SLE patients, which can influence patients’ life quality. Conflicting results exist in risk factors of AVN in SLE patients. The aim of this study was to illustrate risk factors predicting the occurrence of avascular necrosis (AVN), also known as osteonecrosis, in systemic lupus erythematosus (SLE) patients in Chinese SLE Treatment and Research Group (CSTAR), a multi-center cohort of Chinese SLE patients. METHODS: SLE patients in CSTAR without existing AVN at registration were included. At least two follow-ups and an observation period of no less than 2 years for AVN event were required. Univariate and multivariate Cox regression analyses were used to evaluate risk factors for AVN in SLE patients. Coefficient B was transformed to risk score for the development of a risk stratification model. RESULTS: One hundred six (2.59%) of 4091 SLE patients were diagnosed AVN during follow-ups of no less than 2 years. Multi-variate Cox regression analysis suggested that SLE onset age ≤ 30 (HR 1.616, p 0.023), arthritis (HR 1.642, p 0.018), existing organ damage (SDI ≥ 1) at registration (HR 2.610, p < 0.001), positive anti-RNP (HR 1.709, p 0.006), and high glucocorticoid maximum daily dose at registration (HR 1.747, p 0.02) were independent risk factors. A risk stratification system was developed according to the risk factors, and patients were divided into high risk (3–6) and low risk (0–2). The AUC of 0.692 indicated moderate discrimination. The calibration curve in internal validation was drawn. CONCLUSION: Patients with SLE onset age ≤ 30, arthritis, existing organ damage (SDI ≥ 1) at registration, positive anti-RNP, and high glucocorticoid maximum daily dose at registration are at high risk for AVN and require attention. BioMed Central 2023-05-12 2023 /pmc/articles/PMC10176939/ /pubmed/37173771 http://dx.doi.org/10.1186/s13075-023-03061-3 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Cheng, Cheng Huang, Can Chen, Zhen Zhan, Feng Duan, Xinwang Wang, Yongfu Zhao, Cheng Wu, Zhenbiao Xu, Jian Li, Hongbin Yang, Min Wu, Rui Zhao, Jiuliang Zhang, Shangzhu Wang, Qian Leng, Xiaomei Tian, Xinping Li, Mengtao Zeng, Xiaofeng Risk factors for avascular necrosis in patients with systemic lupus erythematosus: a multi-center cohort study of Chinese SLE Treatment and Research Group (CSTAR) Registry XXII |
title | Risk factors for avascular necrosis in patients with systemic lupus erythematosus: a multi-center cohort study of Chinese SLE Treatment and Research Group (CSTAR) Registry XXII |
title_full | Risk factors for avascular necrosis in patients with systemic lupus erythematosus: a multi-center cohort study of Chinese SLE Treatment and Research Group (CSTAR) Registry XXII |
title_fullStr | Risk factors for avascular necrosis in patients with systemic lupus erythematosus: a multi-center cohort study of Chinese SLE Treatment and Research Group (CSTAR) Registry XXII |
title_full_unstemmed | Risk factors for avascular necrosis in patients with systemic lupus erythematosus: a multi-center cohort study of Chinese SLE Treatment and Research Group (CSTAR) Registry XXII |
title_short | Risk factors for avascular necrosis in patients with systemic lupus erythematosus: a multi-center cohort study of Chinese SLE Treatment and Research Group (CSTAR) Registry XXII |
title_sort | risk factors for avascular necrosis in patients with systemic lupus erythematosus: a multi-center cohort study of chinese sle treatment and research group (cstar) registry xxii |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10176939/ https://www.ncbi.nlm.nih.gov/pubmed/37173771 http://dx.doi.org/10.1186/s13075-023-03061-3 |
work_keys_str_mv | AT chengcheng riskfactorsforavascularnecrosisinpatientswithsystemiclupuserythematosusamulticentercohortstudyofchinesesletreatmentandresearchgroupcstarregistryxxii AT huangcan riskfactorsforavascularnecrosisinpatientswithsystemiclupuserythematosusamulticentercohortstudyofchinesesletreatmentandresearchgroupcstarregistryxxii AT chenzhen riskfactorsforavascularnecrosisinpatientswithsystemiclupuserythematosusamulticentercohortstudyofchinesesletreatmentandresearchgroupcstarregistryxxii AT zhanfeng riskfactorsforavascularnecrosisinpatientswithsystemiclupuserythematosusamulticentercohortstudyofchinesesletreatmentandresearchgroupcstarregistryxxii AT duanxinwang riskfactorsforavascularnecrosisinpatientswithsystemiclupuserythematosusamulticentercohortstudyofchinesesletreatmentandresearchgroupcstarregistryxxii AT wangyongfu riskfactorsforavascularnecrosisinpatientswithsystemiclupuserythematosusamulticentercohortstudyofchinesesletreatmentandresearchgroupcstarregistryxxii AT zhaocheng riskfactorsforavascularnecrosisinpatientswithsystemiclupuserythematosusamulticentercohortstudyofchinesesletreatmentandresearchgroupcstarregistryxxii AT wuzhenbiao riskfactorsforavascularnecrosisinpatientswithsystemiclupuserythematosusamulticentercohortstudyofchinesesletreatmentandresearchgroupcstarregistryxxii AT xujian riskfactorsforavascularnecrosisinpatientswithsystemiclupuserythematosusamulticentercohortstudyofchinesesletreatmentandresearchgroupcstarregistryxxii AT lihongbin riskfactorsforavascularnecrosisinpatientswithsystemiclupuserythematosusamulticentercohortstudyofchinesesletreatmentandresearchgroupcstarregistryxxii AT yangmin riskfactorsforavascularnecrosisinpatientswithsystemiclupuserythematosusamulticentercohortstudyofchinesesletreatmentandresearchgroupcstarregistryxxii AT wurui riskfactorsforavascularnecrosisinpatientswithsystemiclupuserythematosusamulticentercohortstudyofchinesesletreatmentandresearchgroupcstarregistryxxii AT zhaojiuliang riskfactorsforavascularnecrosisinpatientswithsystemiclupuserythematosusamulticentercohortstudyofchinesesletreatmentandresearchgroupcstarregistryxxii AT zhangshangzhu riskfactorsforavascularnecrosisinpatientswithsystemiclupuserythematosusamulticentercohortstudyofchinesesletreatmentandresearchgroupcstarregistryxxii AT wangqian riskfactorsforavascularnecrosisinpatientswithsystemiclupuserythematosusamulticentercohortstudyofchinesesletreatmentandresearchgroupcstarregistryxxii AT lengxiaomei riskfactorsforavascularnecrosisinpatientswithsystemiclupuserythematosusamulticentercohortstudyofchinesesletreatmentandresearchgroupcstarregistryxxii AT tianxinping riskfactorsforavascularnecrosisinpatientswithsystemiclupuserythematosusamulticentercohortstudyofchinesesletreatmentandresearchgroupcstarregistryxxii AT limengtao riskfactorsforavascularnecrosisinpatientswithsystemiclupuserythematosusamulticentercohortstudyofchinesesletreatmentandresearchgroupcstarregistryxxii AT zengxiaofeng riskfactorsforavascularnecrosisinpatientswithsystemiclupuserythematosusamulticentercohortstudyofchinesesletreatmentandresearchgroupcstarregistryxxii |